Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Isolated Great Saphenous Vein Stripping for Treatment of Varicose Veins in Lower Limbs

26. maj 2026 opdateret af: Nelson Wolosker, Hospital Israelita Albert Einstein

Clinical Outcomes and Quality of Life Analysis After Concomitant or Sequential Varicose Vein Resection Following Great Saphenous Vein Stripping in Patients With Lower Limb Varicose Veins

The goal of this clinical trial is to compare two surgical approaches for treating varicose veins in the lower limbs in adults: performing varicose vein removal at the same time as great saphenous vein stripping (concomitant) versus performing great saphenous vein treatment alone.

The main questions it aims to answer are:

  • Do clinical outcomes differ between these approaches?
  • Does quality of life improve differently depending on which surgical approach is used?

Participants will:

  • Undergo great saphenous vein stripping for lower limb varicose veins with or without simultaneous varicose vein ressection
  • Be assigned to have varicose vein resection either at the same time or in a subsequent procedure
  • Complete quality of life assessments before and after surgery

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

34

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • São Paulo
      • São Paulo, São Paulo, Brasilien, 05652-900
        • Hospital Israelita Albert Einstein

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Age between 18 and 70 years
  • Varicose veins of the lower limbs with great saphenous vein insufficiency and surgical indication (CEAP C2-C6)
  • Signed informed consent

Exclusion Criteria:

  • Concomitant small saphenous vein insufficiency in the treated limb
  • Previous deep vein thrombosis in the treated limb
  • Previous deep venous insufficiency in the treated limb
  • Previous varicose vein surgery
  • Previous venous interventions (e.g. foam sclerotherapy)
  • Comorbidity or condition that impairs postoperative assessment (e.g. orthopedic diseases of the lower limbs)

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Ikke-randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Conventional Group
Conventional treatment: great saphenous vein stripping + varicose vein removal
Stripping of the great saphenous vein for the treatment of patients with chronic venous disease of the lower limbs associated with great saphenous vein insufficiency
Resection of visible varicose tributaries through staggered mini-incisions
Eksperimentel: Isolated Saphenectomy Group
Saphenous vein stripping without varicose vein removal
Stripping of the great saphenous vein for the treatment of patients with chronic venous disease of the lower limbs associated with great saphenous vein insufficiency

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Quality of life and symptom improvement assessed by the Venous Clinical Severity Score (VCSS) following great saphenous vein stripping in patients with lower limb chronic venous insufficiency
Tidsramme: Changes from baseline at 2 and 6 months of follow-up
VCSS ranges from 0-30; higher scores indicate more severe venous disease
Changes from baseline at 2 and 6 months of follow-up
Quality of life and symptom improvement assessed by the VEINES-QoL/Sym questionnaire following great saphenous vein stripping in patients with lower limb chronic venous insufficiency
Tidsramme: Changes from baseline at 2 and 6 months of follow-up
Original VEINES-QoL/Sym converted to 0-100 scale; higher scores indicate better quality of life
Changes from baseline at 2 and 6 months of follow-up

Sekundære resultatmål

Resultatmål
Tidsramme
Change in the volume of varicose veins assessed by a standardized visual scoring system based on caliber and extent (score range 1-6 per vein, higher scores indicate greater burden) following isolated stripping of the great saphenous vein
Tidsramme: Change in the number and volume of varicose veins in the lower limbs 2 months after surgical treatment
Change in the number and volume of varicose veins in the lower limbs 2 months after surgical treatment

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. februar 2019

Primær færdiggørelse (Faktiske)

28. februar 2024

Studieafslutning (Faktiske)

30. juni 2024

Datoer for studieregistrering

Først indsendt

31. marts 2026

Først indsendt, der opfyldte QC-kriterier

26. maj 2026

Først opslået (Faktiske)

29. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

29. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

26. maj 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • CAAE 69606917.7.3002.0083

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified individual participant data collected during the study may be available to other researchers upon reasonable request. Researchers may request access to de-identified IPD by contacting the corresponding author. Requests will be evaluated by the principal investigator.

IPD-delingstidsramme

Available upon manuscript publication and for 3 years thereafter.

IPD-delingsadgangskriterier

De-identified individual participant data and supporting information will be available to researchers upon reasonable request. Requests should be directed to the corresponding author (fsoaresportela@gmail.com) and will be reviewed by the principal investigator.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Venøs insufficiens

Kliniske forsøg med Great saphenous vein stripping

Abonner